惠泰医疗
(688617)
| 流通市值：384.96亿 | | | 总市值：384.96亿 |
| 流通股本：1.42亿 | | | 总股本：1.42亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,358,012,259.82 | 1,526,351,745.77 | 704,078,336.74 | 2,583,927,321.09 |
| 营业总成本 | 1,459,626,632.52 | 946,822,836.62 | 451,345,627.26 | 1,672,065,165.22 |
| 其他经营收益 | | | | |
| 营业利润 | 934,326,287.77 | 604,064,400.28 | 265,642,094.3 | 944,558,555.84 |
| 利润总额 | 932,392,177.72 | 603,209,707.65 | 265,527,279.38 | 936,290,399.51 |
| 净利润 | 806,058,629.4 | 527,858,916.19 | 225,762,046.92 | 807,739,206.52 |
| 每股收益 | | | | |
| 其他综合收益 | 530,248.6 | 795,464 | -454,815.08 | 406,783.21 |
| 综合收益总额 | 806,588,878 | 528,654,380.19 | 225,307,231.84 | 808,145,989.73 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,421,039,236.7 | 2,045,744,342.83 | 1,882,479,270.46 | 2,122,233,847.44 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,600,027,872.45 | 1,572,707,239.34 | 1,548,025,759.68 | 1,529,622,799.64 |
| 资产总计 | 4,021,067,109.15 | 3,618,451,582.17 | 3,430,505,030.14 | 3,651,856,647.08 |
| 流动负债: | | | | |
| 流动负债合计 | 541,671,674.5 | 437,838,730.65 | 361,857,732.81 | 458,960,421.29 |
| 非流动负债: | | | | |
| 非流动负债合计 | 64,456,729.28 | 61,046,646.21 | 61,543,477.23 | 62,546,856.63 |
| 负债合计 | 606,128,403.78 | 498,885,376.86 | 423,401,210.04 | 521,507,277.92 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,385,186,708.03 | 3,087,316,197.91 | 2,969,091,600.66 | 3,088,667,057.76 |
| 股东权益合计 | 3,414,938,705.37 | 3,119,566,205.31 | 3,007,103,820.1 | 3,130,349,369.16 |
| 负债和股东权益合计 | 4,021,067,109.15 | 3,618,451,582.17 | 3,430,505,030.14 | 3,651,856,647.08 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,764,166,837.64 | 1,804,058,512.59 | 840,665,509.31 | 2,974,884,678.51 |
| 经营活动现金流出小计 | 1,815,946,474.29 | 1,254,773,329.69 | 648,468,567.79 | 2,007,125,019.73 |
| 经营活动产生的现金流量净额 | 948,220,363.35 | 549,285,182.9 | 192,196,941.52 | 967,759,658.78 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,757,280,421.38 | 1,396,185,802.73 | 508,321,312.37 | 2,523,194,329.39 |
| 投资活动现金流出小计 | 2,119,319,214.01 | 1,301,156,661.98 | 612,498,258.32 | 3,042,376,718.21 |
| 投资活动产生的现金流量净额 | -362,038,792.63 | 95,029,140.75 | -104,176,945.95 | -519,182,388.82 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 61,685,336.72 | 53,685,336.72 | 5,985,437.3 | 54,936,123.81 |
| 筹资活动现金流出小计 | 600,958,443.55 | 598,071,868.3 | 356,659,693.2 | 334,680,002.8 |
| 筹资活动产生的现金流量净额 | -539,273,106.83 | -544,386,531.58 | -350,674,255.9 | -279,743,878.99 |
| 汇率变动对现金及现金等价物的影响 | -20,210,357.87 | -15,865,417.01 | -6,876,599.69 | -3,790,697.36 |
| 现金及现金等价物净增加额 | 26,698,106.02 | 84,062,375.06 | -269,530,860.02 | 165,042,693.61 |
| 期末现金及现金等价物余额 | 1,272,828,710.66 | 1,330,192,979.7 | 976,599,744.62 | 1,246,130,604.64 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 84,062,375.06 | - | 165,042,693.61 |
最新报告期：2026-10-31| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中金公司 | 俞波,张琎 | 7.46 | 9.13 | -- | 2026-10-31 |
| 平安证券 | 叶寅,倪亦道,裴晓鹏 | 7.47 | 9.33 | 11.51 | 2026-10-29 |
| 国金证券 | 何冠洲,甘坛焕 | 7.78 | 9.52 | 12.04 | 2026-10-28 |
| 中信建投 | 郑涛,朱琪璋,王在存,贺菊颖 | 7.37 | 9.14 | 11.36 | 2026-09-29 |
| 野村东方国际证券 | 朱小溪 | -- | -- | -- | 2026-09-16 |